Upstream Bio, Inc. Share Price & Technical Analysis
UPB · $8.21 (-1.91%)
Healthcare / Biotechnology
$8.21
-1.91%
Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders. It offers verekitug, which is in Phase 2 trials for the treatment of severe asthma and chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease and in Phase I clinical trial for treating chronic obstructive pulmonary disease. …
Price chart
Seasonality
May has 0 positive and 2 negative years (last 3 years shown)
-9% return in May, -1% avg return in past 3 year May month.
-50% return in 2026, 35% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 14% | -75% | 20% | 0% | -9% | – | – | – | – | – | – | – | -50% |
| 25 | -35% | -24% | -24% | 45% | -1% | 18% | 40% | 16% | 11% | 39% | 10% | -4% | 92% |
| 24 | – | – | – | – | – | – | – | – | – | 15% | -13% | -24% | -22% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Weak
Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders. It offers verekitug, which is in Phase 2 trials for the treatment of severe asthma and chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease and in Phase I clinical trial for treating chronic obstructive pulmonary disease. The company was incorporated in 2021 and is headquartered in Waltham, Massachusetts.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$488.15M
P/E ratio
—
52W high
$33.68
52W low
$7.25
Volume
3,56,489
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Upstream Bio, Inc. share price today?
- Upstream Bio, Inc. (UPB) last traded around $8.21 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does UPB have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for UPB. Download the app for real-time alerts.
- How can I analyze Upstream Bio, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.